{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:19:23Z","timestamp":1788340763734,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejmech.2024.116635","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T18:22:01Z","timestamp":1719598921000},"page":"116635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Antitumor activity and transcriptome sequencing (RNA-seq) analyses of hepatocellular carcinoma cells in response to exposure triterpene-nucleoside conjugates"],"prefix":"10.1016","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-5674","authenticated-orcid":false,"given":"Qiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangchao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongde","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lak Shin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116635_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2024.116635_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1039\/C8LC00970H","article-title":"Microfluidic modeling of the tumor microenvironment for anti-cancer drug development","volume":"19","author":"Shang","year":"2019","journal-title":"Lab Chip"},{"key":"10.1016\/j.ejmech.2024.116635_bib3","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.biopha.2016.10.018","article-title":"Multiple molecular targets in breast cancer therapy by betulinic acid","volume":"84","author":"Luo","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116635_bib4","first-page":"4103","article-title":"Medicinal plants: their use in anticancer therapy","volume":"6","author":"Greenwell","year":"2015","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.ejmech.2024.116635_bib5","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/molecules26041109","article-title":"Plant-derived anticancer compounds as new perspectives in drug discovery and alternative therapy","volume":"26","author":"Dehelean","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116635_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/molbev\/msz254","article-title":"Improving cancer drug discovery by studying cancer across the tree of life","volume":"37","author":"Somarelli","year":"2019","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.ejmech.2024.116635_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11101-019-09623-1","article-title":"Betulin and betulinic acid: triterpenoids derivatives with a powerful biological potential","volume":"18","author":"Hordyjewska","year":"2019","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.ejmech.2024.116635_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/ijms19010263","article-title":"Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application","volume":"19","author":"Seca","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116635_bib9","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/ptr.5669","article-title":"Natural products as mechanism-based anticancer agents: Sp transcription factors as targets","volume":"30","author":"Safe","year":"2016","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2024.116635_bib10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1039\/b810774m","article-title":"Plant-derived gtriterpenoids and analogues as antitumor and anti-HIV agents","volume":"26","author":"Kuo","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2024.116635_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111653","article-title":"Design and synthesis of pentacyclic triterpene conjugates and their use in medicinal research","volume":"182","author":"Hodon","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116635_bib12","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/med.21353","article-title":"Betulinic acid and its derivatives as potential antitumor agents","volume":"35","author":"Zhang","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.116635_bib13","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1021\/jm900136j","article-title":"Anti-aids agents 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents","volume":"52","author":"Qian","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116635_bib14","doi-asserted-by":"crossref","first-page":"344e349","DOI":"10.1111\/cbdd.12251","article-title":"Synthesis of isosteric triterpenoid derivatives and antifungal activity","volume":"83","author":"Innocente","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2024.116635_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/molecules171012003","article-title":"Synthesis and antiplasmodial activity of betulinic acid and ursolic acid analogues","volume":"17","author":"Innocente","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116635_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1021\/acs.jnatprod.5b00709","article-title":"Betulin derivatives effectively suppress inflammation in vitro and in vivo","volume":"79","author":"Laavola","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116635_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ptr.1088","article-title":"Isolation, characterization and biological activity of betulinic acid and ursolic acid from Vitex negundo L","volume":"17","author":"Chandramu","year":"2003","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2024.116635_bib18","article-title":"Antidiabetic effects of betulinic acid mediated by the activation of the AMP-activated protein kinase pathway","volume":"16","author":"Song","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116635_bib19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bmc.2012.11.016","article-title":"Cytotoxic betulin-derived hydroxypropargylamines trigger apoptosis","volume":"21","author":"Csuk","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116635_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1742-7843.2009.00471.x","article-title":"Betulin elicits anti-cancer effects in tumour primary cultures and cell lines in vitro","volume":"105","author":"Rzeski","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2024.116635_bib21","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.ejmech.2010.04.018","article-title":"Small structural changes of pentacyclic lupine type triterpenoid derivatives lead to significant differences in their anticancer properties","volume":"45","author":"Kommera","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116635_bib22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2362.2009.02105.x","article-title":"Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compounds","volume":"39","author":"Willmann","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2024.116635_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/cbdd.12682","article-title":"Betulinic acid: recent advances in chemical modifications, effective delivery, and molecular mechanisms of a promising anticancer therapy","volume":"87","author":"Ali-Seyed","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2024.116635_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3835(01)00718-2","article-title":"Selective cytotoxicity of betulinic acid on tumor cell lines but not on normal cells","volume":"175","author":"Zuco","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2024.116635_bib25","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.bmcl.2010.04.004","article-title":"Carbamate derivatives of betulinic acid and betulin with selective cytotoxic activity","volume":"20","author":"Kommera","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116635_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/CAD.0b013e3283357c62","article-title":"Betulinic acid, a natural compound with potent anticancer effects","volume":"21","author":"Mullauer","year":"2010","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.ejmech.2024.116635_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2007-967106","article-title":"Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L","volume":"73","author":"J\u00e4ger","year":"2007","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2024.116635_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejmech.2017.07.013","article-title":"Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: recent advances in cancer treatment","volume":"142","author":"Salvador","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116635_bib29","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2174\/0929867325666180530095657","article-title":"Delivery system for birch-bark triterpenoids and their derivatives in anticancer research","volume":"27","author":"Mierina","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116635_bib30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1271\/bbb.90917","article-title":"Anticancer activity of 3-Oacylated betulinic acid derivatives obtained by enzymatic synthesis","volume":"74","author":"Ahmad","year":"2010","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ejmech.2024.116635_bib31","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1021\/acsmedchemlett.0c00414","article-title":"Novel betulinic acid-nucleoside hybrids with potent anti-HIV activity","volume":"11","author":"Wang","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116635_bib32","article-title":"A comprehensive review on pyrazoline based heterocyclic hybrids as potent anticancer agents","volume":"5","author":"Haider","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116635_bib33","article-title":"Molecular-docking-guided design, palladium-catalyzed synthesis and anticancer activity of paclitaxel-benzoxazoles hybrids","volume":"12","author":"Jiang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116635_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133692","article-title":"Synthesis of new morpholine-benzimidazole-pyrazole hybrid as tubulin polymerization inhibiting anticancer agents","volume":"1268","author":"Sagam","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116635_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200051","article-title":"Benzimidazole hybrids as anticancer drugs: an updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021)","volume":"355","author":"Feng","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2024.116635_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114651","article-title":"Design, synthesis and biological evaluation of rhein-piperazine-dithiocarbamate hybrids as potential anticancer agents","volume":"241","author":"Wei","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116635_bib37","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1021\/acs.jmedchem.2c00608","article-title":"Novel hybrids of 3-substituted coumarin and phenylsulfonylfuroxan as potent antitumor agents with collateral sensitivity against MCF-7\/ADR","volume":"65","author":"Yu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116635_bib38","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2174\/156802609789909821","article-title":"Pentacyclic triterpenoids and their saponins with apoptosis-inducing activity","volume":"9","author":"Wang","year":"2009","journal-title":"Curr. Top Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116635_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.canlet.2012.02.037","article-title":"Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer","volume":"320","author":"Shanmugam","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2024.116635_bib40","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/mnfr.201400051","article-title":"Ursolic acid triggers nonprogrammed death (necrosis) in human glioblastoma multiforme DBTRG-05MG cells through MPT pore opening and ATP decline","volume":"58","author":"Lu","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejmech.2024.116635_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.phymed.2018.03.035","article-title":"A naturally occurring triterpene saponin ardisiacrispin B displayed cytotoxic effects in multi-factorial drug resistant cancer cells via ferroptotic and apoptotic cell death","volume":"43","author":"Mbaveng","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2024.116635_bib42","first-page":"25","article-title":"Betulinic acid targets drug-resistant human gastric cancer cells by inducing autophagic cell death, suppresses cell migration and invasion, and modulates the ERK\/MEK signaling pathway","volume":"69","author":"Wang","year":"2021","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejmech.2024.116635_bib43","first-page":"104","article-title":"Betulinic acid may modulate autophagy in renal cell carcinoma cells, Bratisl Lek","volume":"124","author":"Atas","year":"2023","journal-title":"Listy"},{"key":"10.1016\/j.ejmech.2024.116635_bib44","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1158\/1078-0432.CCR-07-1595","article-title":"The roles of therapy-induced autophagy and necrosis in cancer treatment","volume":"13","author":"Amaravadi","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116635_bib45","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.biopha.2018.04.072","article-title":"Inhibition of PI3K\/Akt\/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells","volume":"103","author":"Yang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116635_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/13813455.2018.1498901","article-title":"Betulinic acid improves insulin sensitivity, hyperglycemia, inflammation and oxidative stress in metabolic syndrome rats via PI3K\/Akt pathways","volume":"126","author":"Ajala-Lawal","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2024.116635_bib47","first-page":"1669","article-title":"Betulinic acid induces apoptosis by regulating PI3K\/Akt signaling and mitochondrial pathways in human cervical cancer cells","volume":"40","author":"Xu","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2024.116635_bib48","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.biopha.2016.11.028","article-title":"Betulinic acid protects against cerebral ischemia\/reperfusion injury by activating the PI3K\/Akt signaling pathway","volume":"84","author":"Jiao","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116635_bib49","first-page":"6952","article-title":"Betulinic acid induces autophagy-mediated apoptosis through suppression of the PI3K\/AKT\/mTOR signaling pathway and inhibits hepatocellular carcinoma","volume":"11","author":"Liu","year":"2019","journal-title":"Am. J. Transl. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424005154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424005154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:48:01Z","timestamp":1730738881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424005154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":49,"alternative-id":["S0223523424005154"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116635","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor activity and transcriptome sequencing (RNA-seq) analyses of hepatocellular carcinoma cells in response to exposure triterpene-nucleoside conjugates","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116635"}}